Noxopharm Limited

IRM Services
Ticker Code
NOX
Market Cap ($m)
51
Market Cap As At
22/10/2019
GICS Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Company Description
Noxopharm is an Australian drug development company with offices in Melbourne and Sydney. The Company has a primary focus on the development of drugs to address the problem of drug- and radio-resistance in cancer cells, the major hurdle facing improved survival prospects for cancer patients. NOX66 is the first pipeline product, with later generation drug candidates under development in an R&D program.